BET inhibition, including the use of specific chemical BET inhibitors like JQ-1, has many reported effects in vivo in the cardiovascular setting, like preventing intimal hyperplasia, pulmonary arterial hypertension, and cardiac hypertrophy. This evidence concerns the gene DNER and pulmonary arterial hypertension.